(Q40328415)

19 September 2017

1 reference

title

Familial dysbetalipoproteinemia. New aspects of pathogenesis and diagnosis (English)

1 reference

19 September 2017

Havel RJ

1

1 reference

19 September 2017

1 March 1982

1 reference

Medical Clinics of North America

19 September 2017

1 reference

19 September 2017

66

1 reference

19 September 2017

441-454

1 reference

19 September 2017

2

1 reference

Type III Hyperlipoproteinaemia

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies in healthy men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Type-III Hyperlipoproteinaemia ("remnant removal disease"). Insight into the pathogenetic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Effects of estrogen therapy on apolipoprotein E in type III hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Type III Hyperlipoproteinemia: An Analysis of Two Contemporary Definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

1 reference

7 January 2021

Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Hyperlipoproteinemia: Problems in Diagnosis and Challenges Posed by the "Type III" Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Association of isoapolipoprotein-E3 deficiency with heterozygous familial hypercholesterolaemia: implications for lipoprotein physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Abnormal lipid composition of chylomicrons in broad-β disease (type III hyperlipoproteinemia)

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Aggravation of broad- disease (type 3 hyperlipoproteinemia) by hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-β disease (type III hyperlipoproteinemia)

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Broad-beta disease (type III hyperlipoproteinemia) in a large kindred. Evidence for a monogenic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (type 3 hyperlipoproteinemia)

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: relationship to dysbetalipoproteinemia and hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Serum Lipoprotein Concentration and Composition in Healthy 50-year-old Men

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Primary hyperlipoproteinemia in xanthomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Type III Hyperlipoproteinemia: Paradoxical Hypolipidemic Response to Estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Lipoproteins and xanthomatous diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

The Biochemical, Clinical, and Genetic Features of Type III Hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

On thelipoprotein abnormality in type 3 hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

The kinetic properties of very low density lipoprotein triglyceride in type 3 hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Identification and characterization of mixed disulphide complexes of e apoprotein in high density lipoprotein of subjects with acute alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Pancreatic alpha and beta cell function in familial dysbetalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Familial hyperlipoproteinemia type III: Deficiency of a specific apolipoprotein (APO E-III) in the very-low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Polymorphism of apolipoprotein E

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Inheritance of type-III hyperlipoproteinemia. Lipoprotein patterns in first-degree relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

Effects of hyperlipoproteinemias and their treatment on the peripheral circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931429-8

7 January 2021

10.1016/S0025-7125(16)31429-8

Identifiers

DOI

0 references

PubMed ID

7040846

1 reference

PubMed ID

7040846